1. Home
  2. LGVN vs SHPH Comparison

LGVN vs SHPH Comparison

Compare LGVN & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • SHPH
  • Stock Information
  • Founded
  • LGVN 2014
  • SHPH 2012
  • Country
  • LGVN United States
  • SHPH United States
  • Employees
  • LGVN N/A
  • SHPH N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • SHPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGVN Health Care
  • SHPH Health Care
  • Exchange
  • LGVN Nasdaq
  • SHPH Nasdaq
  • Market Cap
  • LGVN 7.8M
  • SHPH 7.5M
  • IPO Year
  • LGVN 2021
  • SHPH 2022
  • Fundamental
  • Price
  • LGVN $3.44
  • SHPH $0.43
  • Analyst Decision
  • LGVN Strong Buy
  • SHPH
  • Analyst Count
  • LGVN 1
  • SHPH 0
  • Target Price
  • LGVN $12.00
  • SHPH N/A
  • AVG Volume (30 Days)
  • LGVN 14.9M
  • SHPH 70.8K
  • Earning Date
  • LGVN 08-09-2024
  • SHPH 08-12-2024
  • Dividend Yield
  • LGVN N/A
  • SHPH N/A
  • EPS Growth
  • LGVN N/A
  • SHPH N/A
  • EPS
  • LGVN N/A
  • SHPH N/A
  • Revenue
  • LGVN $978,000.00
  • SHPH N/A
  • Revenue This Year
  • LGVN $137.24
  • SHPH N/A
  • Revenue Next Year
  • LGVN $50.77
  • SHPH N/A
  • P/E Ratio
  • LGVN N/A
  • SHPH N/A
  • Revenue Growth
  • LGVN N/A
  • SHPH N/A
  • 52 Week Low
  • LGVN $0.77
  • SHPH $0.35
  • 52 Week High
  • LGVN $37.50
  • SHPH $1.05
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 55.56
  • SHPH 52.77
  • Support Level
  • LGVN N/A
  • SHPH N/A
  • Resistance Level
  • LGVN $6.40
  • SHPH $0.46
  • Average True Range (ATR)
  • LGVN 0.52
  • SHPH 0.03
  • MACD
  • LGVN 0.06
  • SHPH -0.01
  • Stochastic Oscillator
  • LGVN 54.47
  • SHPH 95.80

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Share on Social Networks: